Henrik T Sorensen, MD, PhD
Adjunct Professor
Boston University School of Public Health
Dept of Epidemiology

Henrik Toft Sørensen is professor of clinical epidemiology, and is founder and chair of Department of Clinical Epidemiology at Aarhus University Hospital, which was established in 2000. He is a physician and specialist in internal medicine and hepatology, has trained at several major Danish hospitals and acted as a clinician until 2005.

Dr. Sørensen has more than 25 years of experience in clinical and epidemiological research. His research covers, among others, pharmacoepidemiology, epidemiological measures and determinants of the prognosis of several chronic diseases. Dr. Sørensen is author or co-author of more than 1,100 publications and has been supervisor for more than 50 doctoral students.He is member of the Board of Directors of the Danish Council for Independent Research and Editor in Chief of Clinical Epidemiology.

Aarhus University Hospital

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Skajaa N, Horváth-Puhó E, Sundbøll J, Adelborg K, Rothman KJ, Sørensen HT. Forty-year Seasonality Trends in Occurrence of Myocardial Infarction, Ischemic Stroke, and Hemorrhagic Stroke. Epidemiology. 2018 Nov; 29(6):777-783.View Related Profiles. PMID: 30028346.
  2. Kornum JB, Farkas DK, Sværke C, Severinsen MT, Thomsen RW, Sørensen HT. Cancer risk and prognosis after a hospital contact for an elevated erythrocyte sedimentation rate. Cancer Epidemiol Biomarkers Prev. 2018 Oct 23. PMID: 30352816.
  3. Collin LJ, Cronin-Fenton DP, Ahern TP, Christensen KB, Damkier P, Hamilton-Dutoit S, Kjaersgaard A, Lauridsen KL, Yacoub R, Christiansen P, Sørensen HT, Lash TL. Expression of survivin does not appear to influence breast cancer recurrence risk. Acta Oncol. 2018 Oct 23; 1-8. PMID: 30351173.
  4. Ehrenstein V, Kristensen NR, Monz BU, Clinch B, Kenwright A, Sørensen HT. Oseltamivir in pregnancy and birth outcomes. BMC Infect Dis. 2018 Oct 16; 18(1):519. PMID: 30326840.
  5. Horváth-Puhó E, Suttorp MM, Frederiksen H, Hoekstra T, Dekkers OM, Pedersen L, Cannegieter SC, Dekker FW, Sørensen HT. Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma. Clin Epidemiol. 2018; 10:1371-1380. PMID: 30310329.
  6. Ording AG, Öztürk B, Spindler KG, Sørensen HT, McCusker M, Ehrenstein V. KRAS mutation status, comorbidity, and mortality in patients with metastatic colorectal cancer in Denmark. Acta Oncol. 2018 Sep 28; 1-3. PMID: 30264648.
  7. Hansen AT, Veres K, Prandoni P, Adelborg K, Sørensen HT. Retinal vein thrombosis and risk of occult cancer: A nationwide cohort study. Cancer Med. 2018 Sep 27. PMID: 30264545.
  8. Sundbøll J, Darvalics B, Horváth-Puhó E, Adelborg K, Laugesen K, Schmidt M, Henderson VW, Sørensen HT. Preadmission use of glucocorticoids and risk of cardiovascular events in patients with ischemic stroke. J Thromb Haemost. 2018 Nov; 16(11):2175-2183. PMID: 30179297.
  9. Heide-Jørgensen U, Adelborg K, Kahlert J, Sørensen HT, Pedersen L. Sampling strategies for selecting general population comparison cohorts. Clin Epidemiol. 2018; 10:1325-1337. PMID: 30310326.
  10. Søgaard KK, Adelborg K, Darvalics B, Horváth-Puhó E, Beyer-Westendorf J, Ageno W, Sørensen HT. Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population-based cohort study. Lancet Haematol. 2018 Oct; 5(10):e441-e449. PMID: 30201587.
Showing 10 of 1158 results. Show More